M2dicine

M3DICINE is an Australian medical device and digital health company developing AI-enabled connected auscultation tools for human and veterinary care. Its lead product family is Stethee Pro, a wireless electronic stethoscope system paired with mobile software and the M3DICINE Central web portal to capture, visualize, store, and share cardiac and respiratory vital-sign data. The company positions itself as a platform business spanning hardware, software, and artificial intelligence, with machine-learning-based analysis of heart and lung sounds. M3DICINE received U.S. FDA 510(k) clearance in 2020 for Stethee Pro 1, although its current website also states Stethee Pro and Stethee Vet are in development and not available for sale or commercial distribution in any country, suggesting commercialization status may be limited or evolving. The company appears focused on point-of-care monitoring, screening, and decision support rather than therapeutics.